NCT02965703 2026-03-18
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT02647099 2026-03-13
ALASCCA
Karolinska Institutet
Phase 3 Active not recruiting
NCT02394769 2025-12-04
ASPIRED
Massachusetts General Hospital
Phase NA Active not recruiting
NCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04182100 2025-09-15
Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
PharmaEssentia Japan K.K.
Phase 2 Completed
NCT03805932 2025-07-24
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
Phase 1 Active not recruiting
NCT02467582 2025-05-16
Adjuvant Aspirin Treatment for Colon Cancer Patients
Swiss Cancer Institute
Phase 3 Terminated
NCT00357682 2025-05-01
AspECT
University of Oxford
Phase 3 Completed